drugset / Trial / NCT00004937

Acridine Carboxamide in Treating Patients With Recurrent Glioblastoma Multiforme

NCT00004937 ↗

Treatment

Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. PURPOSE: Phase II trial to study the effectiveness of acridine carboxamide in treating patients who have recurrent glioblastoma multiforme.

Timeline

Start
1999-10
Primary completion
2000-05
Completion
—

Drugs

EvaluationDrugModalityDoseRoute
Subject acridine carboxamide Unknown — Intravenous